Your browser doesn't support javascript.
loading
DNA double-strand break repair pathway choice is directed by distinct MRE11 nuclease activities.
Shibata, Atsushi; Moiani, Davide; Arvai, Andrew S; Perry, Jefferson; Harding, Shane M; Genois, Marie-Michelle; Maity, Ranjan; van Rossum-Fikkert, Sari; Kertokalio, Aryandi; Romoli, Filippo; Ismail, Amani; Ismalaj, Ermal; Petricci, Elena; Neale, Matthew J; Bristow, Robert G; Masson, Jean-Yves; Wyman, Claire; Jeggo, Penny A; Tainer, John A.
Afiliação
  • Shibata A; Genome Damage and Stability Centre, University of Sussex, Brighton BN1 9RQ, UK; Advanced Scientific Research Leaders Development Unit, Gunma University, Maebashi, Gunma 371-8511, Japan.
  • Moiani D; Skaggs Institute of Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA; The Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.
  • Arvai AS; Skaggs Institute of Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA; The Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.
  • Perry J; Skaggs Institute of Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA; The Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA; The School of Biotechnology, Amrita University, Kollam, Kerala 690525, India.
  • Harding SM; Departments of Radiation Oncology and Medical Biophysics, University of Toronto, ON M5G 2M9, Canada.
  • Genois MM; Genome Stability Laboratory, Laval University Cancer Research Center, Hôtel-Dieu de Québec, 9 McMahon, QC G1R 2J6, Canada.
  • Maity R; Genome Stability Laboratory, Laval University Cancer Research Center, Hôtel-Dieu de Québec, 9 McMahon, QC G1R 2J6, Canada.
  • van Rossum-Fikkert S; Department of Radiation Oncology, Department of Genetics, Erasmus University Medical Center, P.O. Box 2040, Rotterdam 3000 CA, the Netherlands.
  • Kertokalio A; Department of Radiation Oncology, Department of Genetics, Erasmus University Medical Center, P.O. Box 2040, Rotterdam 3000 CA, the Netherlands.
  • Romoli F; Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Via A. Moro, 53100 Siena, Italy.
  • Ismail A; Genome Damage and Stability Centre, University of Sussex, Brighton BN1 9RQ, UK.
  • Ismalaj E; Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Via A. Moro, 53100 Siena, Italy.
  • Petricci E; Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Via A. Moro, 53100 Siena, Italy.
  • Neale MJ; Genome Damage and Stability Centre, University of Sussex, Brighton BN1 9RQ, UK.
  • Bristow RG; Departments of Radiation Oncology and Medical Biophysics, University of Toronto, ON M5G 2M9, Canada.
  • Masson JY; Genome Stability Laboratory, Laval University Cancer Research Center, Hôtel-Dieu de Québec, 9 McMahon, QC G1R 2J6, Canada.
  • Wyman C; Department of Radiation Oncology, Department of Genetics, Erasmus University Medical Center, P.O. Box 2040, Rotterdam 3000 CA, the Netherlands.
  • Jeggo PA; Genome Damage and Stability Centre, University of Sussex, Brighton BN1 9RQ, UK. Electronic address: p.a.jeggo@sussex.ac.uk.
  • Tainer JA; Skaggs Institute of Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA; The Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA. Electronic address: jatainer@lbl.gov.
Mol Cell ; 53(1): 7-18, 2014 Jan 09.
Article em En | MEDLINE | ID: mdl-24316220
MRE11 within the MRE11-RAD50-NBS1 (MRN) complex acts in DNA double-strand break repair (DSBR), detection, and signaling; yet, how its endo- and exonuclease activities regulate DSBR by nonhomologous end-joining (NHEJ) versus homologous recombination (HR) remains enigmatic. Here, we employed structure-based design with a focused chemical library to discover specific MRE11 endo- or exonuclease inhibitors. With these inhibitors, we examined repair pathway choice at DSBs generated in G2 following radiation exposure. While nuclease inhibition impairs radiation-induced replication protein A (RPA) chromatin binding, suggesting diminished resection, the inhibitors surprisingly direct different repair outcomes. Endonuclease inhibition promotes NHEJ in lieu of HR, while exonuclease inhibition confers a repair defect. Collectively, the results describe nuclease-specific MRE11 inhibitors, define distinct nuclease roles in DSB repair, and support a mechanism whereby MRE11 endonuclease initiates resection, thereby licensing HR followed by MRE11 exonuclease and EXO1/BLM bidirectional resection toward and away from the DNA end, which commits to HR.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fase G2 / Proteínas de Ligação a DNA / Inibidores Enzimáticos / Quebras de DNA de Cadeia Dupla / Reparo do DNA por Junção de Extremidades / Reparo de DNA por Recombinação Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fase G2 / Proteínas de Ligação a DNA / Inibidores Enzimáticos / Quebras de DNA de Cadeia Dupla / Reparo do DNA por Junção de Extremidades / Reparo de DNA por Recombinação Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article